Proof Of Concept : Immunogenicity and Safety of hepB Injection in the Dermis Using VAX-ID
Clinical trial NCT02186977 · COMPLETED
Trial details
- NCT number
- NCT02186977
- Sponsor
- Novosanis NV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2016-12-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.